NASDAQ: NUTXNutex Health Inc Stock
$0.67-0.02 (-2.9%)
Updated Apr 23, 2024
NUTX Price
$0.67
Fair Value Price
$0.94
Market Cap
$33.15M
52 Week Low
$0.50
52 Week High
$9.45
P/E
-0.64x
P/B
0.54x
P/S
0.49x
PEG
N/A
Dividend Yield
N/A
Revenue
$247.65M
Earnings
-$45.79M
Gross Margin
14%
Operating Margin
-13.95%
Profit Margin
-18.5%
Debt to Equity
5.19
Operating Cash Flow
$1M
Beta
1.06
Next Earnings
May 13, 2024
Ex-Dividend
N/A
Next Dividend
N/A
NUTX Overview
Nutex Health Inc. operates micro-hospitals, specialty hospitals, and hospital outpatient departments. It also provides a cloud-based technology platform that aggregates clinical and claims data across multiple settings, information systems, and sources to create a holistic view of patients and providers. Nutex Health was founded in 2011 and is headquartered in Houston, TX.
Zen Score
–
Industry Average (27)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how NUTX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
NUTX ($0.67) is undervalued by 29.29% relative to our estimate of its Fair Value price of $0.94 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
NUTX ($0.67) is significantly undervalued by 29.29% relative to our estimate of its Fair Value price of $0.94 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
NUTX is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more NUTX due diligence checks available for Premium users.
Be the first to know about important NUTX news, forecast changes, insider trades & much more!
NUTX News
Valuation
NUTX fair value
Fair Value of NUTX stock based on Discounted Cash Flow (DCF)
Price
$0.67
Fair Value
$0.94
Undervalued by
28.97%
NUTX ($0.67) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
NUTX ($0.67) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
NUTX is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
NUTX price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-0.64x
Industry
71.4x
Market
41.92x
NUTX price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.54x
Industry
3.4x
NUTX is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
NUTX's financial health
Profit margin
Revenue
$69.7M
Net Income
-$31.6M
Profit Margin
-45.4%
NUTX's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
NUTX's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$398.2M
Liabilities
$319.1M
Debt to equity
5.19
NUTX's short-term assets ($90.85M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
NUTX's long-term liabilities ($260.83M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
NUTX's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
NUTX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$1.8M
Investing
$865.6k
Financing
-$3.9M
NUTX's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
NUTX vs Health Information Service Stocks
Nutex Health Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.